CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Glaukos Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Glaukos Corp
1 GLAUKOS WAY
Phone: (949) 367-9600p:949 367-9600 ALISO VIEJO, CA  92656  United States Ticker: GKOSGKOS
Business Summary
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Thomas W.Burns 63 4/1/2022 3/1/2002
President, Chief Operating Officer Joseph E.Gilliam 48 4/1/2022 5/5/2017
Chief Financial Officer, Senior Vice President Alex R.Thurman 54 4/1/2022 4/1/2022
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
GLAUKOS IRELAND LIMITED 1st Floor The Liffey Trust Centre 117-126 Sheriff Street Upp Ireland
GLAUKOS UK LIMITED 3RD FLOOR CHANCERY HOUSE ST. NICHOLAS WAY UK
Glaukos Netherlands B.V. Kingsfordweg 151 AMSTERDAM NL
6 additional Subsidiary records available in full report.

Business Names
Business Name
Avedro Inc
Avedro, Inc.
Formation
19 additional Business Names available in full report.

General Information
Number of Employees: 995 (As of 12/31/2024)
Outstanding Shares: 57,086,023 (As of 4/4/2025)
Shareholders: 46
Stock Exchange: NYSE
Federal Tax Id: 330945406
Fax Number: (949) 367-9984


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025